Afatinib Impurity 11 | CAS 2413212-17-4 - Request Quote
Afatinib Impurity 11
| SZ CAT No: | SZ-A054023 |
| CAS No | 2413212-17-4 |
| Mol.F. | C22H20ClFN4O3 |
| Mol.Wt. | 442.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Afatinib Impurity 11 is chemically (S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-3-enamide. Afatinib Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Afatinib Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2413212-17-4
Purchase 2413212-17-4
Order 2413212-17-4
Enquire 2413212-17-4
price of 2413212-17-4
2413212-17-4 Supplier
2413212-17-4 Manufacturer
2413212-17-4 Exporter
buy high quality Afatinib Impurity 11
Purchase Afatinib Impurity 11
Afatinib Impurity 11 suppliers
Afatinib Impurity 11 manufacturers
Afatinib Impurity 11 price
Order Afatinib Impurity 11
Enquire Afatinib Impurity 11
Afatinib Impurity 11 cost
Afatinib Impurity 11 Supplier
Afatinib Impurity 11 Distributor
Afatinib Impurity 11 for Method Validation
Afatinib Reference Standard
Afatinib Impurity 11 for ANDA Filing
Afatinib Impurity 11 for Forced Degradation Studies
Afatinib Impurity 11 Identification Standards
Afatinib Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.